HK inno.N Corporation
Research HK inno.N Corporation (195940.KQ) on Bullrun: market cap KRW 1.02T, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker195940.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 1.02T
- Dividend yield1.1%
- Financial periodQ2 2026
- RevenueKRW 267.23B
- Net incomeKRW 13.67B
- Free cash flowKRW 32.92B
- Gross margin44.7%
Valuation Snapshot
latest market cap is KRW 1.02T; dividend yield is 1.1%.
Peer valuation comparison
Latest dividend yield is 1.14% versus a Healthcare sector median of 2.4% (52.5% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 1.02T | n/a | 1.1% | 410 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 410 KRW, yield 1.1%.
About HK inno.N Corporation
HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, and hypertension with dyslipidemia;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HK inno.N Corporation's market cap?
HK inno.N Corporation's market capitalization is KRW 1.02T.
Does HK inno.N Corporation pay a dividend?
HK inno.N Corporation has a dividend yield of 1.1%.
What does HK inno.N Corporation do?
HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, and hypertension with dyslipidemia; GERD, EE, NERD, GU and H.Pylori; pleural mesothelioma, non-small cell lung cancer, and mesothelioma, and.